Back to User profile » Dr Francisco Ampudia-Blasco
Paper published by Dr Francisco Ampudia-Blasco:
Commentary
Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
Ampudia-Blasco FJ, Romera I, Ariño B, Gomis R
International Journal of General Medicine 2017, 10:23-26
Published Date: 13 January 2017